Why is Aarti Drugs falling/rising?

As of 12-Aug, Aarti Drugs Ltd is currently priced at 488.00, reflecting a decrease of 0.3, or 0.06%. The stock has been underperforming recently, having fallen for three consecutive days, resulting in a total decline of 3.69% during this period. Despite this, the stock has shown a positive return of 1.39% over the past week and 3.04% over the past month, which contrasts with the Sensex's declines of 0.59% and 2.75%, respectively. However, the stock's delivery volume has significantly decreased, falling by 67.67% against the 5-day average, indicating reduced investor participation. The stock's moving averages suggest it is trading higher than the 50-day, 100-day, and 200-day averages but lower than the 5-day and 20-day averages.
In the broader market context, Aarti Drugs' recent performance is notable as it has outperformed the Sensex in the short term, with a 1-week return of 1.39% compared to the benchmark's decline. The company benefits from strong management efficiency, as indicated by a high return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45, which supports its valuation. Despite a year-over-year return of -4.27%, the company's profits have increased by 20.4%, suggesting underlying strength. The stock is currently trading at a discount compared to its peers, which may attract investors looking for value, although the recent drop in delivery volume could signal caution among traders.